Marginal zone B cell lymphoma of the parotid glands: Results of a randomised trial comparing radiotherapy to combined therapy

European Journal of Cancer Part B: Oral Oncology

Volumn 32, Issue 6, 1996, Pages 420-422

  Aviles A ^a,b   Delgado, S ^a   Huerta Guzman J ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b NONE   (Mexico)

Author keywords

Combined therapy; Malignancy lymphoma; Marginal zone B cell lymphoma; Monocytoid B cell lymphoma; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PAROTID GLAND CANCER; PRIORITY JOURNAL; SURVIVAL; TOXICITY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PAROTID NEOPLASMS; PROSPECTIVE STUDIES; RADIOTHERAPY, HIGH-ENERGY; SURVIVAL RATE;

EID: 0030294095     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0964-1955(96)00031-0     Document Type: Article

References (13)

1. 1. Sheibani K, Suhn CC, Burke JS, Weinberg CD, Wu AM, Rappaport H. Monocytoid B cell lymphoma. Am J Pathol 1986, 124, 310-318.
2. 2. Sheibani K, Burke JS, Schwartz WG, Nademanec A, Weinberg CD. Monocytoid B cell lymphoma. Cancer 1988, 62, 1531-1538.
3. 3. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms. A proposal for the International Lymphoma Study Group. Blood 1994, 84, 1361-1391.
4. 4. Shih SS, Sheibani K, Fishleder A, et al. Monocytoid B cell lymphoma in patients with Sjöegren syndrome. Hum Pathol 1991, 22, 422-430.
5. 5. Aozasa K, Matsumoto M, Katigiri S, et al. Monocytoid B cell lymphoma arising in extranodal organs. Cancer 1991, 67, 2305-2310.
6. 6. Traweek T, Sheibani K, Weinberg CD, Mena RR, Wu AM, Rappaport H. Monocytoid B cell lymphoma. Its evolution and relationship to other low-grade B cell lymphoma. Blood 1988, 73, 573-578.
7. 7. Mollejo M, Menarguez J, Cristobal E, et al. Monocytoid B cells. A comparative clinical pathological study of their distribution in different types of low-grade lymphomas. Am J Surg Pathol 1994, 18, 1131-1139.
8. 8. Emanuelle S, Saven A, Kosty M, Ellison D, Piro L. 2-Chlorodeoxyadenosine activity in patients with untreated low-grade lymphoma. Proc Am Soc Clin Oncol 1994, 13, 1002 (abstr).
9. 9. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53, 457-481.
10. 10. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol 1994, 25, 1020-1029.
11. 11. Gospodarowitz MK, Sutcliffe SB. The extranodal lymphoma. Semin Radiat Oncol 1995, 5, 281-300.
12. 12. Fisher RI, Dahlberg S, Nathwani B, Banks PM, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B cell subcategories). A Southwest Oncology Group Study. Blood 1995, 85, 1075-1082.
13. 13. Avilés A, Díaz-Maqueo JC, Sánchez E, Ayala JR, Córtes HD. Long term results in patients with low-grade nodular non-Hodgkin's lymphoma. Acta Oncol 1991, 30, 329-333.